Rekombinanter SIRPA Antikörper
Kurzübersicht für Rekombinanter SIRPA Antikörper (ABIN7797289)
Target
Alle SIRPA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- SIRPA Recombinant Monoclonal Antibody
-
Aufreinigung
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from Human SIRPA
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC:1:50-1:200, FC:1:50-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SIRPA (Signal-Regulatory Protein alpha (SIRPA))
-
Andere Bezeichnung
- SIRPA
-
Hintergrund
- Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a), SIRPA, BIT MFR MYD1 PTPNS1 SHPS1 SIRP
-
UniProt
- P78324
Target
-